Nipah virus the rising epidemic: A review

Infezioni in Medicina

Volumn 27, Issue 2, 2019, Pages 117-127

  Ochani, Rohan Kumar ^a   Batra, Simran ^a   Shaikh, Asim ^a   Asad, Ameema ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Nipah virus; Outbreaks; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; NUCLEOPROTEIN;

ANTIBODY TITER; AREFLEXIA; ARTICLE; CELL MEMBRANE; CLIMATE CHANGE; DISEASE TRANSMISSION; DIZZINESS; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EXPOSURE THERAPY; FEVER; GENETIC VARIABILITY; GENOME; HENIPAVIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MYOCLONUS; NIPAH VIRUS; NIPAH VIRUS INFECTION; ORTHOPOXVIRUS; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; RISK MANAGEMENT; RNA SYNTHESIS; SANGER SEQUENCING; SERODIAGNOSIS; SEROPREVALENCE; SYSTEMATIC REVIEW; VACCINATION; VIREMIA; VIRUS GENOME; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; ZIKA VIRUS; ANIMAL; ASIA; BAT; CAT; COMMUNICABLE DISEASE; DISEASE CARRIER; DOG; GENETICS; HENIPAVIRUS INFECTION; HORSE; ISOLATION AND PURIFICATION; PIG; PINOCYTOSIS; PROCEDURES; SYMPTOM ASSESSMENT; VETERINARY MEDICINE; VIROLOGY; VIRUS ENTRY;

ANIMALS; ASIA; CATS; CHIROPTERA; COMMUNICABLE DISEASES, EMERGING; DISEASE RESERVOIRS; DOGS; EPIDEMICS; HENIPAVIRUS INFECTIONS; HORSES; HUMANS; NIPAH VIRUS; PINOCYTOSIS; SWINE; SYMPTOM ASSESSMENT; VACCINATION; VIRUS INTERNALIZATION;

EID: 85068218528     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Eaton B.T., Broder C.C., Middleton D., Wang L.F. Hendra and Nipah viruses: Different and dangerous. Nat. Rev. Microbiol. 4, 1, 23-25, 2006.
2. Lo Presti A., Cella E., Giovanetti M., et al. Origin and evolution of Nipah virus. J. Med. Virol. 88, 3, 380-388, 2016.
3. Lo M.K., Rota P.A. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J. Clin. Virol. 43, 4, 396-400, 2008.
4. Centers for Disease Control and Prevention. Nipah Virus (NiV): Risk of Exposure. 2014. Retrieved from: Https://www.cdc.gov/vhf/nipah/exposure/index. html. Last accessed November 05, 2018.
5. Wong K.T., Shieh W.J., Kumar S., et al. Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol. 161, 6, 2153-2167, 2002.
6. Harcourt B.H., Tamin A., Halpin K., et al. Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology. 287, 1, 192-201, 2001.
7. Cox R.M., Plemper R.K. Structure and organization of paramyxovirus particles. Curr. Opin. Virol. 24, 105-114, 2017.
8. Rockx B., Winegar R., Freiberg A.N. Recent progress in henipavirus research: Molecular biology, genetic diversity, animal models. Antiviral. Res. 95, 2, 135-149, 2012.
9. Dutch R.E. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 6, 6, e1000881, 2010.
10. Luby S.P., Gurley E.S., Hossain M.J. Transmission of human infection with Nipah virus. In: Institute of Medicine (US). Improving Food Safety Through a One Health Approach: Workshop Summar. 2009, 49, 000-000. Washington (DC). National Academies Press (US).
11. Centers for Disease Control and Prevention. Nipah Virus (NiV). 2014. Retrieved from https://www.cdc. gov/vhf/nipah/index.html. Last accessed November 06, 2018.
12. Deka M.A., Morshed N. Mapping disease transmission risk of Nipah virus in south and southeast Asia. Trop. Med. Infect. Dis. 3, 2, 57, 2018.
13. Arunkumar G., Chandni R., Mourya D.T., et al. NIPAH: Nipah Investigators People And Health. Outbreak investigation of Nipah Virus Disease in Kerala, India, 2018. J. Infect. Dis. 2018. doi: 10.1093/infdis/jiy612.
14. [14 Mathieu C., Horvat B. Henipavirus pathogenesis and antiviral approaches. Expert Rev. Anti Infect. Ther. 13, 3, 343-354, 2015.
15. Weingarti H. Hendra and Nipah viruses: Pathogenesis, animal models and recent breakthroughs in vaccination. Vaccine: Development and Therapy. 5, 59-74, 2015.
16. World Health Organization South-East Asia. Information regarding Nipah virus. Retrieved from http:// www.searo.who.int/entity/emerging_diseases/links/ information_regarding_nipah_virus/en/. Last accessed November 29, 2018.
17. Wong K.T., Tan C.T. Clinical and pathological manifestations of human henipavirus infection. Curr. Top. Microbiol. Immunol. 359, 95-104, 2012.
18. Goh K.J., Tan C.T., Chew N.K., et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N. Engl. J. Med. 342, 17, 1229-1235, 2000.
19. Hossain M.J., Gurley E.S., Montgomery J., et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin. Infect. Dis. 46, 7, 977-984, 2008.
20. Wang L.F., Daniels P. Diagnosis of henipavirus infection: Current capabilities and future directions. Curr. Top. Microbiol. Immunol. 359, 179-196, 2012.
21. Guillaume V., Lefeuvre A., Faure C., et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J. Virol. Methods. 120, 2, 229-237, 2014.
22. Food and Agriculture Organization of the United Nations. 2001. Retrieved from http://www.fao.org/docrep/ 005/AC449E/ac449e07.htm. Last accessed November 18, 2018.
23. Kaku Y., Noguchi A., Marsh G.A., et al. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: Sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J. Virol. Methods. 179, 1, 226-232, 2012.
24. Chua K.B., Wong E.M., Cropp B.C., Hyatt A.D. Role of electron microscopy in Nipah virus outbreak investigation and control. Med. J. Malaysia. 62, 2, 139-142, 2007.
25. Lo M.K., Lowe L., Hummel K.B., et al. Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010. Emerg. Infect. Dis. 18(2), 248-255, 2012.
26. Arunkumar G. Manipal Academy of Higher Education. Laboratory Investigations During Nipah Virus Outbreak in Kerala work done and gaps identified. Retrieved from http://www.searo.who.int/entity/research_policy/meetings/2.4_laboratory_investigations_duringniv_virus_outbreak_kerala_2018.pdf? ua=1. Last accessed February 02, 2019.
27. Centers for Disease Control and Prevention. Nipah Virus (NiV): Diagnosis. 2014. Retrieved from https:// www.cdc.gov/vhf/nipah/diagnosis/index.html. Last accessed November 10, 2018.
28. Arunkumar G., Abdulmajeed J., Devadiga S., et al. Persistence of Nipah virus RNA in semen of survivor. Clin. Infect. Dis. 2018. doi: 10.1093/cid/ciy1092.
29. [ 29] Chong H.T., Kamarulzaman A. Tan C.T., et al. Treatment of acute Nipah encephalitis with ribavirin. Ann. Neurol. 49, 6, 810-813, 2001.
30. Broder C.C., Xu K., Nikolov D.B., et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral. Res. 100, 1, 8-13, 2013.
31. Lo M.K., Jordan P.C., Stevens S., et al. Susceptibility of paramyxoviruses and filoviruses to inhibition by 2’-monofluoro-and 2’-difluoro-4’-azidocytidine analogs. Antiviral. Res. 153, 101-113, 2018.
32. Dawes B.E., Kalveram B, Ikegami T, et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci. Rep. 8, 1, 7604, 2018.
33. World Health Organization. Nipah Virus. 2018. Retrieved from http://www.who.int/news-room/fact-sheets/detail/ nipah-virus. Last accessed November 27, 2018.
34. Hassan M.Z., Sazzad H.M.S., Luby S.P., et al. Nipah virus contamination of hospital surfaces during outbreaks, Bangladesh, 2013-2014. Emerg. Infect. Dis 24, 1, 15-20, 2018.
35. The times of India. Measures to prevent Nipah taken. 2018. Retrieved from https://timesofindia.indiatimes. com/city/coimbatore/measures-to-prevent-nipah-taken/articleshow/64328597.cms. Last accessed November 10, 2018.
36. Weingartl H.M., Berhane Y., Caswell J.L., et al. Recombinant Nipah virus vaccines protect pigs against challenge. J. Virol. 80, 16, 7929-7938, 2006.
37. DeBuysscher B.L., Scott D., Marzi A., Prescott J., Feldmann H. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 32, 22, 2637-2644, 2014.
38. Satterfield B.A., Dawes B.E, Milligan G.N. Status of vaccine research and development of vaccines for Nipah virus. Vaccine. 34, 26, 2971-2975, 2016.
39. CEPI. CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine. May 24, 2018. Retrieved from http://www.profectusbiosciences.com/pdfs/releases/2018%200524%20Profectus%20CEPI%20Partnership%20Nipah%20Virus%20Vaccine.pdf. Last accessed February 01, 2019.
40. Hosono H., Kono H., Ito S., Shirai J. Economic impact of Nipah virus infection outbreak in Malaysia. Proceedings of the 11th International Symposium on Veterinary Epidemiology and Economics. 2006. Retrieved from http://www.sciquest.org.nz/elibrary/download/ 63964/T6-1.3.1+-+Economic+impact+of+nipah+-virus+infection+outbreak+in+Malaysia. Last accessed November 10, 2018.
41. Nahar N., Asaduzzaman M., Sultana R., et al. A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: Components and costs. BMC Res. Notes. 10, 1, 225, 2017.